Indolent Lymphoma Global Clinical Trials Review, Q1, 2011

GlobalData, January 2011, Pages: 30

Indolent Lymphoma Global Clinical Trials Review, Q1, 2011

Summary

Our clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, Q1, 2011" provides data on the Indolent Lymphoma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Indolent Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables
List of Figures
Introduction
Indolent Lymphoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Subjects Recruited Over a Period of Time
Prominent Sponsors
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
S-BIO Pte Ltd
Clinical Trial Overview of S-BIO Pte Ltd
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Fred Hutchinson Cancer Research Center-Technology Transfer
Clinical Trial Overview of Fred Hutchinson Cancer Research Center-Technology Transfer
Ohio State University Comprehensive Cancer Center
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center
The Cancer Biotherapy Research Group
Clinical Trial Overview of The Cancer Biotherapy Research Group
The Cleveland Clinic
Clinical Trial Overview of The Cleveland Clinic
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
Clinical Trial Overview of Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
Tel-Aviv Sourasky Medical Center
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
National Cancer Institute (NCI)
Clinical Trial Overview of National Cancer Institute (NCI)
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Indolent Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2011-
Indolent Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Indolent Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Indolent Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Indolent Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010--
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by S-BIO Pte Ltd, 2011-
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 2011-
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2011-
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cancer Biotherapy Research Group, 2011-
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2011-
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Arthur G. James Cancer Hospital & Richard J. Solove Research Institute, 2011-
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2011-
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2011-
Indolent Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2011-

List of Figures
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Indolent Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011-
Indolent Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Indolent Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Indolent Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Methodology

Customers who bought this item also bought

• Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology
• Strabismus Global Clinical Trials Review, H1, 2013
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Alopecia Global Clinical Trials Review, H1, 2013
• Ulcers Global Clinical Trials Review, H1, 2013
• Otitis Media Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Cholangitis Global Clinical Trials Review, H1, 2013
• Peptic Ulcers Global Clinical Trials Review, H2, 2012